Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-30

Clinical Trial Update: Treatment of Tendon Injury Using Allogenic Adipose-derived Mesenchymal Stem Cells (Rotator Cuff Tear) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating allogenic adipose-derived mesenchymal stem cells for rotator cuff tear has completed with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Allogenic Adipose-Derived Mesenchymal Stem Cells

Snippet

Sponsor: Seoul National University Hospital | Conditions: Rotator Cuff Tear | Phase 2 | Status: COMPLETED | Results posted: 2021-06-30